Similarly, researchers found that CYT387, a specific JAK inhibitor, inhibited osteoclast activity and alleviated ovariectomy-induced osteoporosis in mice through modulating the RANKL and ROS signaling pathways, suggesting that JAK inhibitors may be valuable in the prevention or treatment of osteoporosis. The gene discussed is TNFSF11; the disease is osteoporosis.